Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

RiVax ricin toxin vaccine protective in macaque model

Feb. 12, 2015

University of Texas discloses new sigma-receptor ligands

Feb. 10, 2015

Biotie Therapies reports topline results from nepicastat study in cocaine dependence

Feb. 2, 2015

Novel treatment for cocaine addiction TV-1380 safe in healthy subjects

Jan. 29, 2015

Takeda launches fomepizole in Japan for ethylene glycol and methanol poisoning

Jan. 27, 2015

Invion reports interim data from phase II trial of oral INV-102 in smoking cessation

Jan. 21, 2015

Evotec and C4X Discovery collaborate to discover OX1 receptor inhibitors for addiction

Jan. 19, 2015

Dr. Reddy's completes acquisition of Habitrol

Dec. 24, 2014

Temple University prepares and tests novel glutamate uptake modulators

Dec. 23, 2014

Noribogaine HCl safe and well tolerated in healthy volunteers

Dec. 12, 2014

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...